Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C. Nichols, David A. Palma, Khalil Sultanem et al.|The Lancet Oncology|2019Cited by 459